首页 | 本学科首页   官方微博 | 高级检索  
检索        

神经内分泌肿瘤核医学显像剂的研究进展
引用本文:刘炳楠,王颖,要少波.神经内分泌肿瘤核医学显像剂的研究进展[J].国际放射医学核医学杂志,2020,44(9):582-588.
作者姓名:刘炳楠  王颖  要少波
作者单位:1.天津医科大学总医院血液内科,300052
摘    要:核医学显像作为无创性功能影像检查手段,在神经内分泌肿瘤诊断中发挥着重要作用。核医学显像的关键点在于分子靶向探针,目前已报道用于神经内分泌肿瘤显像的核医学分子探针可分为靶向生长抑素受体类和其他类,其中,靶向生长抑素受体类显像剂又可分为生长抑素受体激动剂和拮抗剂。笔者对用于神经内分泌肿瘤诊断的核医学显像剂进行综述。

关 键 词:癌,神经内分泌    放射性核素显像    放射性示踪剂
收稿时间:2019-06-10

Research progress of nuclear medicine imaging tracers for neuroendocrine neoplasma
Bingnan Liu,Ying Wang,Shaobo Yao.Research progress of nuclear medicine imaging tracers for neuroendocrine neoplasma[J].International Journal of Radiation Medicine and Nuclear Medicine,2020,44(9):582-588.
Authors:Bingnan Liu  Ying Wang  Shaobo Yao
Institution:1.Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China
Abstract:Nuclear medicine imaging, as a noninvasive functional imaging method, plays a vital role in the diagnosis of neuroendocrine neoplasma. Nuclear medicine imaging relies on molecular targeted tracers. According to the published papers, nuclear medicine imaging tracers for neuroendocrine neoplasma can be divided into somatostatin receptor-targeted tracers and other types, and the former contains somatostatin receptor agonists and antagonists. In this paper, nuclear medicine imaging tracers for neuroendocrine neoplasma are reviewed.
Keywords:
点击此处可从《国际放射医学核医学杂志》浏览原始摘要信息
点击此处可从《国际放射医学核医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号